Announcements Trials
Browse Landscape

Phase

Phase 1 3

Status

Completed 2Active not recruiting 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 3Sarcoma 2Lymphoid 2Genitourinary 2CNS 2Thoracic 1Plasma cell 1Other solid neoplasm 1Other hematologic neoplasm 1Breast 1

Conditions

Neoplasms 2Neoplasm Metastasis 2

Interventions

pembrolizumab 94Paclitaxel 85Gemcitabine 83Carboplatin 79Docetaxel 60Cisplatin 58Bevacizumab 58Nivolumab 56Fluorouracil 47Capecitabine 46Magnetic Resonance Spectroscopy 44Radiotherapy 41Irinotecan 40Oxaliplatin 38Erlotinib Hydrochloride 37Pemetrexed 34Leucovorin 34Biopsy 34atezolizumab 33Cetuximab 32Standard of Care 31Trastuzumab 28Cyclophosphamide 28Radiosurgery 27Blood Specimen Collection 27Specimen Handling 26Sorafenib 26Ipilimumab 26Everolimus 26olaparib 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Suspensions × Tumor-Agnostic × Clear all
NCT04898543 2025-12-11

QUILT-3.076: Study of Autologous M-CENK in Subjects With Locally Advanced or Metastatic Solid Tumors

ImmunityBio, Inc.

Phase 1 Active not recruiting
50 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT03027128 2024-11-20

QUILT-3.028: Study of haNKâ„¢ for Infusion in Subjects With Metastatic or Locally Advanced Solid Tumors

ImmunityBio, Inc.

Phase 1 Completed
6 enrolled 10 charts
Tumor-Agnostic

Neoplasm Metastasis, Neoplasms

NCT04727138 2022-05-16

3-part Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of EXS21546

Exscientia AI Limited

Phase 1 Completed
64 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡